Semiquantitative X-ray Powder Diffraction Analysis in Counterfeit Medicines Investigation-The Viagra Example

被引:0
|
作者
Budzianowski, Armand [1 ]
Piorunska-Sedlak, Karolina [2 ]
Poplawska, Magdalena [2 ]
Maurin, Jan K. [2 ]
Blazewicz, Agata [2 ]
机构
[1] Natl Ctr Nucl Res, Andrzeja Soltana 7, PL-05400 Otwock, Poland
[2] Natl Med Inst, Chelmska 30-34, PL-00725 Warsaw, Poland
关键词
Viagra; sildenafil; X-ray powder diffraction; XRPD; semiquantitative analysis; falsified medicines; CRYSTALLOGRAPHY OPEN DATABASE; OPEN-ACCESS COLLECTION; SILDENAFIL CITRATE; INHIBITORS; DRUGS;
D O I
10.3390/cryst13101485
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
Have you ever looked at a powder diffractogram during a routine qualitative test and wondered how much of a particular powder compound is in the powder material? Several methods can work this out, but none of them could be used in our case because something was missing from each in performing a rapid quantity test for an active ingredient in a tablet. A semiquantitative method of an X-ray powder diffraction analysis of products containing sildenafil citrate is proposed. This method utilizes calibration curves for the most common compositions encountered in falsified and not-registered Viagra analogues. Sildenafil doses are established for singularly prepared powder probes of a medicinal product, and two runs of data collection are used: the first, the fast one, for the qualitative analysis of the product, and the second for selected 2 theta regions for the API and identified excipients. An example of a product composed mainly of sildenafil citrate, gypsum and microcrystalline cellulose is discussed in detail. The data obtained from X-ray experiments were compared with the results obtained from validated liquid chromatography coupled to a diode array detector and mass spectrometry methods.
引用
收藏
页数:34
相关论文
共 50 条
  • [1] The usefulness of simple X-ray powder diffraction analysis for counterfeit control -: The Viagra® example
    Maurin, Jan K.
    Plucinski, Franciszek
    Mazurek, Aleksander P.
    Fijalek, Zbigniew
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) : 1514 - 1518
  • [2] X-ray powder diffraction analysis of tegafur
    Needham, F.
    Faber, J.
    Fawcett, T. G.
    Olson, D. H.
    POWDER DIFFRACTION, 2006, 21 (03) : 245 - 247
  • [3] X-ray powder diffraction analysis of imipenem monohydrate
    Needham, F.
    Crowder, C. E.
    Reid, J. W.
    Fawcett, T. G.
    Faber, J.
    POWDER DIFFRACTION, 2012, 27 (01) : 20 - 24
  • [4] X-ray powder diffraction data for schisanhenol
    Zhang, Li Li
    Xiao, Dan
    Lin, Xia
    Luo, Wei
    Li, Si
    Li, Hui
    POWDER DIFFRACTION, 2014, 29 (01) : 48 - 50
  • [5] X-ray powder diffraction data for levetiracetam
    Xu, Kai Lin
    Liang, Bing
    Wu, Xiao Qing
    Zhang, Li Li
    Tang, Pei Xiao
    Li, Hui
    POWDER DIFFRACTION, 2014, 29 (01) : 51 - 52
  • [6] X-ray powder diffraction data for norandrostenedione
    Tang, Pei Xiao
    Wu, Xiao Qing
    Pan, Qing Qing
    Zhang, Li Li
    Cheng, Qiang
    Li, Hui
    POWDER DIFFRACTION, 2013, 28 (04) : 302 - 304
  • [7] X-ray powder diffraction data for deoxyschisandrin
    Zhang, Li Li
    Pan, Qing Qing
    Xiao, Dan
    Wu, Xiao Qing
    Wang, Qing
    Li, Hui
    POWDER DIFFRACTION, 2013, 28 (03) : 231 - 233
  • [8] X-ray powder diffraction data for norethindrone
    Tang, Pei Xiao
    Wu, Xiao Qing
    Zhang, Li Li
    Cheng, Qiang
    Li, Hui
    POWDER DIFFRACTION, 2014, 29 (01) : 46 - 47
  • [9] X-ray powder diffraction data for peiminine
    Xiao, Dan
    Zhang, Li Li
    Wu, Xiao Qing
    Yan, Jin
    Luo, Wei
    Li, Hui
    POWDER DIFFRACTION, 2013, 28 (04) : 312 - 314
  • [10] Powder X-ray diffraction data of BaFI
    Subramanian, N
    Shekar, NVC
    Sahu, PC
    Yousuf, M
    Rajan, KG
    POWDER DIFFRACTION, 2000, 15 (02) : 130 - 133